Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients.
Meng QH, Krahn J
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of in vivo heparin administration and collection anticoagulant on plasma and serum albumin levels by the BCG and BCP methods.
Summary of Findings
No effect of in vivo administration of heparin on albumin concentration in serum or plasma collected in EDTA, or heparinized tubes was observed in a single patient by either the BCP or the BCG method. However, collection of plasma in lithium heparin tubes resulted in significantly lower albumin levels by the BCG method than BCP in 30 non-renal patients (31.2 versus 34.1 g/L, p<0.001) and 30 hemodialysis patients (28.6 versus 32.8 g/L, p<0.001). The effect of heparin on plasma albumin levels was dose dependent. Heparinized plasma albumin levels were significantly lower from serum albumin levels only when quantified by BCG (31.2 versus 34.8 in non-renal patients p<0.001). Further, no effect of quantification method was observed on serum albumin levels. In conclusion, while in vivo heparin administration does not alter albumin quantification, the presence of lithium heparin in the collection tube caused decreased albumin quantification by the BCG but not BCP method.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
Other diagnosesNormalPlatforms
ProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Renal failure on hemodialysisPreaquisition Other drugs HeparinBiospecimen Acquisition Anticoagulant EDTALithium heparinBiospecimen Aliquots and Components Blood and blood products PlasmaSerumClinical chemistry/auto analyzer Specific Technology platform Bromocresol green (Roche)Bromocresol purple (Beckman)